On Monday, Tenaya Therapeutics Inc (NASDAQ: TNYA) opened higher 5.59% from the last session, before settling in for the closing price of $3.58. Price fluctuations for TNYA have ranged from $1.61 to $7.01 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 19.57% at the time writing. With a float of $65.58 million, this company’s outstanding shares have now reached $79.22 million.
Let’s look at the performance matrix of the company that is accounted for 140 employees. In terms of profitability, gross margin is 58.87%, operating margin of -694.87%, and the pretax margin is -663.65%.
Tenaya Therapeutics Inc (TNYA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tenaya Therapeutics Inc is 17.22%, while institutional ownership is 57.30%. The most recent insider transaction that took place on Nov 18 ’24, was worth 4,787. In this transaction SVP, Accounting and Fin. Ops. of this company sold 2,258 shares at a rate of $2.12, taking the stock ownership to the 60,983 shares. Before that another transaction happened on Aug 16 ’24, when Company’s SVP, Accounting and Fin. Ops. sold 2,363 for $2.89, making the entire transaction worth $6,840. This insider now owns 63,241 shares in total.
Tenaya Therapeutics Inc (TNYA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.57% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Check out the current performance indicators for Tenaya Therapeutics Inc (TNYA). In the past quarter, the stock posted a quick ratio of 5.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.25 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics Inc (NASDAQ: TNYA) saw its 5-day average volume 4.03 million, a positive change from its year-to-date volume of 1.11 million. As of the previous 9 days, the stock’s Stochastic %D was 81.69%. Additionally, its Average True Range was 0.36.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 88.57%, which indicates a significant decrease from 90.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 108.82% in the past 14 days, which was higher than the 105.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.30, while its 200-day Moving Average is $3.43. Nevertheless, the first resistance level for the watch stands at $3.95 in the near term. At $4.12, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.28. If the price goes on to break the first support level at $3.62, it is likely to go to the next support level at $3.46. Assuming the price breaks the second support level, the third support level stands at $3.29.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are currently 79,221K shares outstanding in the company with a market cap of 299.45 million. Presently, the company’s annual sales total 0 K according to its annual income of -124,080 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -25,630 K.
